Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance

Multidrug‐resistant Acinetobacter baumannii is a top‐priority pathogen globally and polymyxins are a last‐line therapy. Polymyxin dependence in A. baumannii (i.e., nonculturable on agar without polymyxins) is a unique and highly‐resistant phenotype with a significant potential to cause treatment failure in patients. The present study discovers that a polymyxin‐dependent A. baumannii strain possesses mutations in both lpxC (lipopolysaccharide biosynthesis) and katG (reactive oxygen species scavenging) genes. Correlative multiomics analyses show a significantly remodeled cell envelope and remarkably abundant phosphatidylglycerol in the outer membrane (OM). Molecular dynamics simulations and quantitative membrane lipidomics reveal that polymyxin‐dependent growth emerges only when the lipopolysaccharide‐deficient OM distinctively remodels with ≥ 35% phosphatidylglycerol, and with “patch” binding on the OM by the rigid polymyxin molecules containing strong intramolecular hydrogen bonding. Rather than damaging the OM, polymyxins bind to the phosphatidylglycerol‐rich OM and strengthen the membrane integrity, thereby protecting bacteria from external reactive oxygen species. Dependent growth is observed exclusively with polymyxin analogues, indicating a critical role of the specific amino acid sequence of polymyxins in forming unique structures for patch‐binding to bacterial OM. Polymyxin dependence is a novel antibiotic resistance mechanism and the current findings highlight the risk of ‘invisible’ polymyxin‐dependent isolates in the evolution of resistance.

[1]  K. Ko,et al.  Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  K. Ko,et al.  Development of colistin dependence in non-baumannii Acinetobacter species. , 2018, International journal of antimicrobial agents.

[3]  M. Powers,et al.  Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics , 2018, Proceedings of the National Academy of Sciences.

[4]  J. Li,et al.  Lipidomic Analysis of the Outer Membrane Vesicles from Paired Polymyxin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates , 2018, International journal of molecular sciences.

[5]  Brian T. Tsuji,et al.  Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa , 2018, Antimicrobial Agents and Chemotherapy.

[6]  K. Ko,et al.  Transition of colistin dependence into colistin resistance in Acinetobacter baumannii , 2017, Scientific Reports.

[7]  P. Nordmann,et al.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes , 2017, Clinical Microbiology Reviews.

[8]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[9]  R. Hancock,et al.  Polymyxin: Alternative Mechanisms of Action and Resistance. , 2016, Cold Spring Harbor perspectives in medicine.

[10]  K. Peters,et al.  A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii , 2016, Proceedings of the National Academy of Sciences.

[11]  Brian T. Tsuji,et al.  Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens , 2016, Scientific Reports.

[12]  K. Ko,et al.  High rate of colistin dependence in Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.

[13]  Yusen Liu,et al.  KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst. , 2016, Life sciences.

[14]  Matthew D. Johnson,et al.  Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii , 2016, Scientific Reports.

[15]  M. McConnell,et al.  Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. , 2015, International journal of antimicrobial agents.

[16]  Kelsey A. Gregg,et al.  A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii , 2015, Antimicrobial Agents and Chemotherapy.

[17]  Matthew D. Johnson,et al.  Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol. , 2015, The Journal of antimicrobial chemotherapy.

[18]  Berk Hess,et al.  GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .

[19]  J. Boyce,et al.  The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model. , 2015, The Journal of antimicrobial chemotherapy.

[20]  H. Hayden,et al.  Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii , 2015, Journal of bacteriology.

[21]  Richard B. Sessions,et al.  Interaction of the Antimicrobial Peptide Polymyxin B1 with Both Membranes of E. coli: A Molecular Dynamics Study , 2015, PLoS Comput. Biol..

[22]  Pan‐Chyr Yang,et al.  Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour , 2015, Nature Communications.

[23]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[24]  C. Stathopoulos,et al.  Linezolid-Dependent Function and Structure Adaptation of Ribosomes in a Staphylococcus epidermidis Strain Exhibiting Linezolid Dependence , 2014, Antimicrobial Agents and Chemotherapy.

[25]  Cary L. Honnold,et al.  AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments , 2014, mBio.

[26]  Jesmin Akter,et al.  Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria , 2014, Bioconjugate chemistry.

[27]  J. Li,et al.  Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’ , 2014, ACS chemical biology.

[28]  Jesmin Akter,et al.  A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity , 2013, The Journal of Antibiotics.

[29]  Oliver Fiehn,et al.  LipidBlast - in-silico tandem mass spectrometry database for lipid identification , 2013, Nature Methods.

[30]  T. Lithgow,et al.  Assembly of the Type II Secretion System such as Found in Vibrio cholerae Depends on the Novel Pilotin AspS , 2013, PLoS pathogens.

[31]  E. Burd,et al.  Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway , 2012, Antimicrobial Agents and Chemotherapy.

[32]  J. Boyce,et al.  Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine , 2011, Antimicrobial Agents and Chemotherapy.

[33]  T. Piggot,et al.  Electroporation of the E. coli and S. Aureus membranes: molecular dynamics simulations of complex bacterial membranes. , 2011, The journal of physical chemistry. B.

[34]  R. Epand,et al.  Bacterial membrane lipids in the action of antimicrobial agents , 2011, Journal of peptide science : an official publication of the European Peptide Society.

[35]  Jens Krüger,et al.  CELLmicrocosmos 2.2 MembraneEditor: A Modular Interactive Shape-Based Software Approach To Solve Heterogeneous Membrane Packing Problems , 2011, J. Chem. Inf. Model..

[36]  J. Boyce,et al.  Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii , 2011, Antimicrobial Agents and Chemotherapy.

[37]  Jian Li,et al.  Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.

[38]  Anton Y Peleg,et al.  Hospital-acquired infections due to gram-negative bacteria. , 2010, The New England journal of medicine.

[39]  Jian Li,et al.  Structure--activity relationships of polymyxin antibiotics. , 2010, Journal of medicinal chemistry.

[40]  J. Turnidge,et al.  Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models , 2009, Antimicrobial Agents and Chemotherapy.

[41]  M. Adams,et al.  Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System , 2009, Antimicrobial Agents and Chemotherapy.

[42]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[43]  C. Murray,et al.  Development of Colistin-Dependent Acinetobacter baumannii-Acinetobacter calcoaceticus Complex , 2007, Antimicrobial Agents and Chemotherapy.

[44]  G. Archer,et al.  Identification and Phenotypic Characterization of a β-Lactam-Dependent, Methicillin-Resistant Staphylococcus aureus Strain , 2007, Antimicrobial Agents and Chemotherapy.

[45]  J. Turnidge,et al.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.

[46]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[47]  L. Actis,et al.  Genetic and Phenotypic Analysis of Acinetobacter baumannii Insertion Derivatives Generated with a Transposome System , 2002, Applied and Environmental Microbiology.

[48]  L. Gutmann,et al.  Vancomycin dependence in a vanA-producing Enterococcus avium strain with a nonsense mutation in the natural D-Ala-D-Ala ligase gene , 1997, Antimicrobial agents and chemotherapy.

[49]  N. Farrag,et al.  Vancomycin-dependent Enterococcus faecalis , 1996, The Lancet.

[50]  H. Nikaido,et al.  Molecular basis of bacterial outer membrane permeability. , 1985, Microbiological reviews.

[51]  S. Nosé.  A molecular dynamics method for simulations in the canonical ensemble , 1984 .

[52]  M. Parrinello,et al.  Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .

[53]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[54]  G. Lindblom,et al.  Lipid Bilayer Stability in Biological Membranes , 1984 .